Clinical trials

Browse topics  Search all clinical trials

Clinical trials : gyn-cancer

Showing 1 -1 of 1 results
A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) with Olaparib & Cediranib) Compared to Olaparib & Cediranib or Durvalumab (MEDI4736) & Cediranib or SOC Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
This phase II trial studies the possible benefits of treatment with different combinations of the drugs durvalumab, olaparib and cediranib vs. the usual treatment in patients with ovarian, primary peritoneal, or fallopian tube cancer that has come back after a period of improvement with platinum therapy (recurrent platinum resistant)...

Monter Cancer Center | 450 Lakeville Road | Lake Success | NY 11042
(888) 321-DOCS

Our representatives are available to schedule your appointment Monday through Friday from 9am to 5pm.

For a Northwell ambulance, call
(833) 259-2367.
Quick links
Connect
About
Policies

Employees

We are Northwell Health—and together, we're raising the standard of health care.
For employees

© Copyright 2025 Northwell Health. As an official 501(c)(3) nonprofit organization, your gift is tax-deductible as allowed by law.

Policies